An Open‐Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7‐Day Triple Therapy With Bismuth Versus 14‐Day Standard Triple Therapy for <scp> <i>Helicobacter pylori</i> </scp> Eradication in Children and Adolescents